Home » Antithrombotic Therapy Administered by End of Hospital Day Two
Print this page

Release Notes:
Data Element
Version 2010A1

Data Element Name: Antithrombotic Therapy Administered by End of Hospital Day Two
Collected For: ,
Definition:Documentation demonstrates that antithrombotic therapy was administered by the end of hospital day two
Suggested Data Collection Question:Was antithrombotic therapy administered by the end of hospital day two?
Format:
Length:
Type:Alphanumeric
Occurs:
Allowable Values:

Y     (Yes, antithrombotic therapy was administered by the end of hospital day 2)

N    (No, antithrombotic therapy was not administered by the end of hospital day 2 OR unable to determine from medical record documentation)

NC    (No, antithrombotic therapy was not administered. A documented reason exists for not administering this therapy)

Notes for Abstraction:
Antithrombotic Therapy:
Aspirin (ASA)
ASA/dipyridamole (Aggrenox) (bid)
warfarin (Coumadin)
clopidogrel (Plavix)
ticlopidine (Ticlid)
Unfractionated heparin IV
Full dose LMW heparin

To compute end of hospital day two, count the arrival date as hospital day one. If antithrombotic therapy was administered by 11:59 PM of hospital day two, answer “Yes” for this data element. E.g, Patient arrives at the hospital on Monday at 05:00, answer “Yes” if antithrombotic therapy was administered on or before 23:59 on Tuesday. If patient arrived at the hospital at 23:30 on Monday, answer “Yes” if antithrombotic therapy was administered on or before 23:59 on Tuesday.

Reasons for not prescribing antithrombotic therapy must be documented by a physician, nurse practitioner or physician assistant. If reasons are not mentioned in the context of antithrombotics, do not make inferences (e.g., do not assume that antrithombotics are not being prescribed because of a bleeding disorder unless documentation explicitly states so.)

Conditions or factors making the administration of antithrombotic therapy inadvisable, inappropriate and/or undesirable are documented (appropriate response is “NC”, a documented reason exists for not administering this therapy). This may include:

  • Allergy to or complication r/t antithrombotic (hx/current)
  • Aortic dissection (current)
  • Bleeding disorder
  • Brain/CNS cancer (hx/current)
  • CVA, hemorrhagic (hx/current)
  • Extensive/metastatic CA (hx/current)
  • Hemorrhage, any type (hx/current)
  • Intracranial surgery/biopsy (current)
  • Patient refusal
  • Peptic ulcer (current)
  • Planned surgery within 7 days following discharge
  • Risk of bleeding (current)
  • Thrombolytic therapy (tPA) administered within past 24 hours
  • Unrepaired intracranial aneurysm (hx/current)
  • Other (patient/physician)
Suggested Data Sources:
  • Progress notes
  • Physician orders
  • Medication records
  • Clinical logs
Additional Notes:
Guidelines for Abstraction:
Inclusion Exclusion
  • None
  • None

Antithrombotic Therapy Administered by End of Hospital Day Two
Specifications Manual for Joint Commission National Quality Core Measures (2010A1)
Discharges 04-01-10 (2Q10) through 09-30-10 (3Q10)